Valuation: Fresenius SE & Co. KGaA

Capitalization 23.07B 27.15B 21.11B 19.93B 37.17B 2,565B 37.5B 250B 97.63B 1,232B 102B 99.73B 4,253B P/E ratio 2026 *
12.2x
P/E ratio 2027 * 11x
Enterprise value 33.43B 39.35B 30.59B 28.88B 53.86B 3,716B 54.34B 363B 141B 1,785B 148B 145B 6,162B EV / Sales 2026 *
1.41x
EV / Sales 2027 * 1.32x
Free-Float
72.99%
Yield 2026 *
2.8%
Yield 2027 * 3.01%
1 day+0.54%
1 week-0.70%
Current month-0.70%
1 month-8.47%
3 months-17.68%
6 months-14.02%
Current year-16.37%
1 week 38.18
Extreme 38.18
41.8
1 month 38.18
Extreme 38.18
45.2
Current year 38.18
Extreme 38.18
52.96
1 year 38.18
Extreme 38.18
52.96
3 years 23.93
Extreme 23.93
52.96
5 years 19.69
Extreme 19.69
52.96
10 years 19.69
Extreme 19.69
80.07
Manager TitleAgeSince
Chief Executive Officer 57 2022-09-30
Director of Finance/CFO 46 2022-08-31
Compliance Officer 50 -
Director TitleAgeSince
Director/Board Member 71 2015-05-19
Director/Board Member 65 2016-05-12
Director/Board Member 52 2015-12-31
Change 5d. change 1-year change 3-years change Capi.($)
+0.54%-0.70%-4.48%+61.01% 27.15B
+3.65%+10.31%+33.46%+29.95% 116B
+1.44%+0.48%+22.96%+56.67% 96.54B
-1.52%-0.67%+2.15%+14.18% 20.84B
-1.81%-2.74%+6.53%+39.09% 20.74B
+0.22%-7.80%-17.04%-23.72% 20.85B
+1.51%-0.16%+13.68%+61.58% 17.2B
-1.93%+3.88%+27.72%+173.14% 16.4B
+1.22%+30.99%+38.31%+122.68% 12.75B
+0.38%-3.29%-25.23%-12.35% 11.8B
Average +0.37%+2.58%+9.81%+52.22% 35.98B
Weighted average by Cap. +1.46%+3.74%+18.53%+45.90%

Financials

2026 *2027 *
Net sales 23.65B 27.84B 21.65B 20.43B 38.11B 2,629B 38.45B 257B 100B 1,263B 104B 102B 4,361B 24.86B 29.26B 22.75B 21.47B 40.05B 2,763B 40.4B 270B 105B 1,327B 110B 107B 4,582B
Net income 1.9B 2.24B 1.74B 1.64B 3.06B 211B 3.09B 20.62B 8.04B 101B 8.39B 8.21B 350B 2.13B 2.5B 1.94B 1.84B 3.42B 236B 3.45B 23.07B 8.99B 113B 9.38B 9.19B 392B
Net Debt 10.36B 12.19B 9.48B 8.95B 16.69B 1,152B 16.84B 112B 43.84B 553B 45.74B 44.78B 1,910B 9.64B 11.35B 8.82B 8.33B 15.53B 1,072B 15.67B 105B 40.8B 515B 42.57B 41.68B 1,777B
Logo Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (59.2%; Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (37.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.; - other (3.1%).
Employees
177,783
Date Price Change Volume
26-05-08 40.96 +0.54% 1,512,339
26-05-07 40.74 +2.13% 1,319,432
26-05-06 39.89 +1.14% 2,597,553
26-05-05 39.44 -3.36% 1,944,905
26-05-04 40.81 -1.07% 963,184
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
40.96EUR
Average target price
55.08EUR
Spread / Average Target
+34.47%

Quarterly revenue - Rate of surprise